10,245 Shares in Definitive Healthcare Corp. (NASDAQ:DH) Bought by Norden Group LLC

Norden Group LLC bought a new position in shares of Definitive Healthcare Corp. (NASDAQ:DHFree Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 10,245 shares of the company’s stock, valued at approximately $83,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Massachusetts Financial Services Co. MA increased its holdings in Definitive Healthcare by 76.0% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,466,514 shares of the company’s stock valued at $34,457,000 after buying an additional 1,496,652 shares during the period. Vanguard Group Inc. increased its holdings in Definitive Healthcare by 6.2% in the 3rd quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company’s stock valued at $34,609,000 after buying an additional 254,726 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Definitive Healthcare by 209.8% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,209 shares of the company’s stock valued at $161,000 after buying an additional 10,977 shares during the period. M&T Bank Corp increased its holdings in Definitive Healthcare by 34.1% in the 4th quarter. M&T Bank Corp now owns 108,024 shares of the company’s stock valued at $1,073,000 after buying an additional 27,442 shares during the period. Finally, Victory Capital Management Inc. increased its holdings in Definitive Healthcare by 2.4% in the 4th quarter. Victory Capital Management Inc. now owns 275,883 shares of the company’s stock valued at $2,742,000 after buying an additional 6,450 shares during the period. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Performance

Shares of NASDAQ:DH opened at $5.29 on Wednesday. The firm’s 50 day simple moving average is $5.64 and its 200 day simple moving average is $7.55. Definitive Healthcare Corp. has a fifty-two week low of $4.38 and a fifty-two week high of $12.45. The company has a market capitalization of $623.85 million, a price-to-earnings ratio of -3.02, a P/E/G ratio of 3.87 and a beta of 1.30. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.30 and a quick ratio of 2.30.

Definitive Healthcare (NASDAQ:DHGet Free Report) last posted its earnings results on Tuesday, May 7th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.04). The firm had revenue of $63.48 million during the quarter, compared to analyst estimates of $64.00 million. Definitive Healthcare had a positive return on equity of 0.51% and a negative net margin of 78.16%. As a group, sell-side analysts forecast that Definitive Healthcare Corp. will post 0.1 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Definitive Healthcare from $10.00 to $7.00 and set a “hold” rating on the stock in a report on Thursday, May 9th. Canaccord Genuity Group lowered their target price on shares of Definitive Healthcare from $10.00 to $8.00 and set a “hold” rating on the stock in a report on Wednesday, May 8th. Morgan Stanley lowered shares of Definitive Healthcare from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $11.50 to $9.00 in a report on Wednesday, May 8th. Barclays lowered their target price on shares of Definitive Healthcare from $11.00 to $7.00 and set an “equal weight” rating on the stock in a report on Thursday, May 9th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Wednesday, May 8th. Nine equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $9.94.

Read Our Latest Stock Analysis on DH

Definitive Healthcare Profile

(Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Stories

Want to see what other hedge funds are holding DH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Definitive Healthcare Corp. (NASDAQ:DHFree Report).

Institutional Ownership by Quarter for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.